Gladstone Institutional Advisory LLC Fortress Biotech, Inc. Transaction History

Gladstone Institutional Advisory LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.42 - $3.65 $26,474 - $39,931	-10,940 Closed	0 $0
Q4 2020 Jan 27, 2023	SELL	$2.2 - $4.45 $1,100 - $2,225	-500 Reduced 4.37%	10,940 $35,000
Q4 2020 Feb 16, 2021	SELL	$2.2 - $4.45 $1,100 - $2,225	-500 Reduced 4.37%	10,940 $35,000
Q3 2020 Jan 27, 2023	BUY	$2.62 - $4.78 $29,972 - $54,683	11,440 New	11,440 $46,000
Q3 2020 Nov 16, 2020	BUY	$2.62 - $4.78 $2,620 - $4,780	1,000 Added 9.58%	11,440 $46,000
Q1 2020 May 14, 2020	BUY	$1.14 - $2.96 $11,901 - $30,902	10,440 New	10,440 $20,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $173M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.